Alzheimer's Disease

If that comes true we'll be headline in the top news in Germany and probably around Europe at least because it's a little bit of a calculations and calculated at the lower end of an antibody per year let's make it cheap. "This is just more spammed than I think the healthcare system actually in the moment spends overall," he says. The incentives should be said for how many patients can you help and then you can say and also make good benefit for the company, Schulte adds.